| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.3 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |